Skip to main content
PAINWeek 2025 Main banner
Icon Legend
This session is not in your agenda.
This session is in your agenda. Click to remove it

  1. Home

  • Thursday, Sep 4th
    9:35 AM - 9:45 AM PST
    SAP-01 - (Scientific Abstract Presentation) Should I test for Novel Psychoactive Substances (NPS) in Clinical Specimens?
    Location:  Exhibit Hall (Level 4)
    Poster Presenter: Jillian Neifeld, MS, D-ABFT-FT – Quest Diagnostics
    Scientific Abstract Live Presentations
  • Thursday, Sep 4th
    9:50 AM - 10:00 AM PST
    SAP-02 - (Scientific Abstract Presentation) No Pill Security In The Home
    Location:  Exhibit Hall (Level 4)
    Poster Presenter: John Hsu, MD – iPill inc
    Scientific Abstract Live Presentations
    Sponsored By iPill
  • Thursday, Sep 4th
    4:05 PM - 4:15 PM PST
    SAP-03 - (Scientific Abstract Presentation) Results of a Randomized, Placebo-Controlled, Phase 3 Trial of Cebranopadol for the Treatment of Acute Pain After Abdominoplasty
    Location:  Exhibit Hall (Level 4)
    Poster Presenter: James Hackworth, PhD – Tris Pharma, Inc.
    Scientific Abstract Live Presentations
    Sponsored By 
  • Thursday, Sep 4th
    4:20 PM - 4:30 PM PST
    SAP-04 - (Scientific Abstract Presentation) A prospective, real-world evidence study evaluating the effect of topical diclofenac (Voltaren gel) on functional mobility and quality of life in adults with osteoarthritis of the knee
    Location:  Exhibit Hall (Level 4)
    Poster Presenter: Karin Nicholson, PhD, BCMAS – Haleon
    Scientific Abstract Live Presentations
    Sponsored By 
  • Thursday, Sep 4th
    4:35 PM - 4:45 PM PST
    SAP-05 - (Scientific Abstract Presentation) Pharmacokinetics study comparing MR-107A-02 (novel fast-acting meloxicam formulation) 15mg tablet with meloxicam (Mobic®) 15mg in healthy adult male subjects
    Location:  Exhibit Hall (Level 4)
    Poster Presenter: Matthew A. Hummel, Ph.D. – Viatris
    Scientific Abstract Live Presentations
    Sponsored By 
  • Thursday, Sep 4th
    4:50 PM - 5:00 PM PST
    SAP-06 - (Scientific Abstract Presentation) Efficacy and safety of MR-107A-02 (novel fast-acting meloxicam formulation) for the treatment of acute moderate-to-severe pain following bunionectomy
    Location:  Exhibit Hall (Level 4)
    Poster Presenter: Jessica C. McCoun, MD – CenExel ACMR Atlanta
    Scientific Abstract Live Presentations
    Sponsored By 
  • Thursday, Sep 4th
    5:05 PM - 5:15 PM PST
    SAP-07 - (Scientific Abstract Presentation) Efficacy and safety of MR-107A-02 (novel meloxicam fast-acting formulation) for the treatment of acute moderate-to-severe pain following herniorrhaphy
    Location:  Exhibit Hall (Level 4)
    Poster Presenter: Jessica C. McCoun, MD – CenExel ACMR Atlanta
    Scientific Abstract Live Presentations
    Sponsored By 
  • Thursday, Sep 4th
    5:20 PM - 5:30 PM PST
    SAP-08 - (Scientific Abstract Presentation) Opioid sparing effect of MR-107A-02 (novel fast-acting meloxicam formulation) for the treatment of acute moderate-to-severe pain following bunionectomy and herniorrhaphy
    Location:  Exhibit Hall (Level 4)
    Poster Presenter: Susanne R. Vogt, n/a – Viatris
    Scientific Abstract Live Presentations
    Sponsored By